Glesatinib
Glesatinib(MGCD265) is an orally bioavailable potent dual inhibitor of c-MET and SMO. Glesatinib counteracts P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC).
| Trivial name | MGCD265 |
| Catalog Number | E1340 |
| Molecular Formula | C19H19N5O |
| CAS# | 936694-12-1 |
| Size | 100mg |
| Supplier Page | http://www.selleckchem.com/products/glesatinib.html |
| Additional Information | https://file.selleck.cn/downloads/struct/E1340-Glesatinib-chemical-structure.png |